Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Ischemic Heart Disease

Free Subscription 12.10.2026 1 Am Heart J 1 Am J Cardiol 1 Am J Emerg Med 2 Am J Med 2 Angiology 1 Arterioscler Thromb Vasc Biol 1 Atherosclerosis 3 Can J Cardiol 1 Cardiovasc Res 1 Catheter Cardiovasc Interv 1 Circ Res 5 Circulation 6 Clin Cardiol 1 Crit Care Med 4 Eur Heart J 2 J Am Coll Cardiol 4 J Cardiovasc Pharmacol 1 J Clin Endocrinol Metab 1 J Thorac Cardiovasc Surg 3 JAMA 2 Mol Cell Biochem 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. CAVENDER MA, Jastreboff AM, Cheng AYY, Davies MJ, et al
   Design and baseline characteristics of the CagriSema cardiovascular outcomes trial (REDEFINE 3).
   Am Heart J. 2026 Oct 6:107626. doi: 10.1016/j.ahj.2026.107626.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

2. MA X, Jiang J, Wei Y, Lan C, et al
   Apolipoprotein(a) Isoform Size and Lipoprotein(a) Concentration and Acute Myocardial Infarction Risk in China: the INTERHEART China Study.
   Am J Cardiol. 2026 Oct 6:S0002-9149(26)00593.
   PubMed         Abstract available
   
   

   
   Am J Emerg Med

3. BISHOP A, Bain C, Meadley B
   Exploratory evaluation of a medical vision-language model for electrocardiographic detection of acute coronary occlusion.
   Am J Emerg Med. 2026;110:551-554.
   PubMed         Abstract available
   
   

   
   Am J Med

4. SULTAN S, Ahmed A, Nounu M, Sultan S, et al
   Microplastics and Nanoplastics as a Novel Cardiovascular Risk Factor: A Narrative Review.
   Am J Med. 2026 Oct 6:S0002-9343(26)00734-5. doi: 10.1016/j.amjmed.2026.
   PubMed         Abstract available
   
   
5. GENOVESE C, Rizzo CE, Maisano D, Squeri R, et al
   Herpes Zoster as a Trigger of Cardiovascular Events: A Systematic Review of Epidemiological Evidence and Pathophysiological Mechanisms.
   Am J Med. 2026 Oct 4:S0002-9343(26)00737-0. doi: 10.1016/j.amjmed.2026.
   PubMed         Abstract available
   
   

   
   Angiology

6. GAO S
   Letter: Contemporary Trends, Outcomes, and Novel Risk Score for Spontaneous Coronary Artery Dissection: A Nationwide Analysis.
   Angiology. 2026 Oct 8:33197261496378. doi: 10.1177/00033197261496378.
   PubMed        
   
   
7. EROL ALGUL NI, Erzurum M, Felekoglu MA, Ozerdem ME, et al
   Prognostic Value of the CALLY Index in Predicting Contrast-Associated Acute Kidney Injury in Patients With Acute Coronary Syndrome.
   Angiology. 2026 Oct 7:33197261494019. doi: 10.1177/00033197261494019.
   PubMed         Abstract available
   
   

   
   Arterioscler Thromb Vasc Biol

8. TARIQ A, Sohn W, Lee YJ, Kim YS, et al
   Wearable Sensors and Remote Patient Monitoring in Cardiovascular Disease: From Continuous Physiological Surveillance to Actionable Insights.
   Arterioscler Thromb Vasc Biol. 2026 Oct 8. doi: 10.1161/ATVBAHA.126.324766.
   PubMed         Abstract available
   
   

   
   Atherosclerosis

9. YU Y, Li D, Shan D, Wang Y, et al
   Effect of in-hospital initiation of alirocumab on clinical outcomes in Chinese ACS patients: findings from the Chinese Cardiovascular Association (CCA) Database-Chest Pain Center.
   Atherosclerosis. 2026;421:121864.
   PubMed         Abstract available
   
   

   
   Can J Cardiol

10. NAMMALWAR S, Elsherbini A, Sallam A, Razavi AA, et al
    Mid-term Outcomes After Robotic Coronary Artery Bypass Grafting in the United States.
    Can J Cardiol. 2026;42:2492-2500.
    PubMed         Abstract available
    
    
11. YAMAMOTO MH, Mizukami T, Mori H, Kobayashi N, et al
    Two-Year Outcomes of Optical Coherence Tomography-Guided Percutaneous Coronary Intervention Stratified by Underlying Causes of Acute Coronary Syndrome.
    Can J Cardiol. 2026;42:2310-2319.
    PubMed         Abstract available
    
    
12. HENDRIANUS H, Lee SY, Won H, Jeong YH, et al
    Intravascular Imaging-guided Percutaneous Coronary Intervention in Patients With and Without Diabetes: A Meta-analysis of Randomized Trials.
    Can J Cardiol. 2026;42:2344-2355.
    PubMed         Abstract available
    
    

    
    Cardiovasc Res

13. LENELL J, Flores Tomasino G, Han D, Wolny R, et al
    Improved plaque composition from intensive medical treatment in women with angina and non-obstructive coronary disease.
    Cardiovasc Res. 2026 Oct 7:cvag174. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Catheter Cardiovasc Interv

14. AMMOURY C, Ramu SK, Rajendran J, Besir B, et al
    Phenotype-Based Risk Stratification in Patients With New-Onset Atrial Fibrillation Following Myocardial Infarction Using a Data-Driven Approach.
    Catheter Cardiovasc Interv. 2026 Oct 7. doi: 10.1002/ccd.70923.
    PubMed         Abstract available
    
    

    
    Circ Res

15. CREMONESI M, Kallikourdis M
    Cardio-Immunologic Dissection of Myocardial Infarction After CMV Infection.
    Circ Res. 2026;139:e329684.
    PubMed        
    
    

    
    Circulation

16. WANG Y, Li Y, Xing G
    Letter by Wang et al Regarding Article, "Association of Statin Discontinuation in Pregnancy With Maternal Cardiovascular Health and Birth Outcomes: A Nationwide Cohort Study".
    Circulation. 2026;154:e520-e521.
    PubMed        
    
    
17. STAVRAKIS S
    Vagal Nerve Stimulation for Cardiovascular Diseases: From Hype to Hope.
    Circulation. 2026;154:1287-1289.
    PubMed        
    
    
18. CHO Y, Kang D, Shin JY, Choi KH, et al
    Response by Cho et al to Letters Regarding Article, "Association of Statin Discontinuation in Pregnancy with Maternal Cardiovascular Health and Birth Outcomes: A Nationwide Cohort Study".
    Circulation. 2026;154:e522-e523.
    PubMed        
    
    
19. LU CW
    Letter by Lu Regarding Article, "Association of Statin Discontinuation in Pregnancy With Maternal Cardiovascular Health and Birth Outcomes".
    Circulation. 2026;154:e518-e519.
    PubMed        
    
    
20. MIAO ZW, Chen CX, Wang P, Zheng SL, et al
    Metrnl Reduces Thrombosis and Acute Myocardial Injury Through Inhibition of Platelet Activation via CD36 Receptor Degradation.
    Circulation. 2026 Aug 18. doi: 10.1161/CIRCULATIONAHA.126.077134.
    PubMed         Abstract available
    
    

    
    Clin Cardiol

21. ROMERO MARTINEZ VDC, Tobon Cuenca JP, Longas Garcia PA, Salazar Moreno LE, et al
    Screening Strategies for Silent Myocardial Ischemia in Individuals With Diabetes Without Known Coronary Artery Disease: Systematic Review and Meta-Analysis.
    Clin Cardiol. 2026;49:e70470.
    PubMed         Abstract available
    
    
22. OZBAY MB, Ozen Y, Ozbay B
    Response to Commentary on the Prognostic Value of the Naples Prognostic Score After PCI in Acute Coronary Syndrome.
    Clin Cardiol. 2026;49:e70485.
    PubMed        
    
    
23. MA X, Yuan B
    Association Between Hemoglobin Glycation Index and Prevalence of Cardiovascular Disease in Middle-Aged and Older Adults With Hip Fracture: Findings From CHARLS and NHANES.
    Clin Cardiol. 2026;49:e70481.
    PubMed         Abstract available
    
    
24. MOHSEN-POUR N, Esmaeili S, Feyzi A, Sharafi A, et al
    From Genomics to Precision Cardiology: A Comprehensive Review of Clinical Applications and Challenges in Cardiovascular Diseases.
    Clin Cardiol. 2026;49:e70482.
    PubMed         Abstract available
    
    
25. AKKAYA F, Bahadir N
    Clarification of Reported Statistical Inconsistencies in a CHA2DS2-VA Analysis of No-Reflow After Primary Percutaneous Coronary Intervention.
    Clin Cardiol. 2026;49:e70478.
    PubMed        
    
    
26. RABIEE RAD M, Darouei B, Ghasempour Dabaghi G, Amani-Beni R, et al
    National and Subnational Trends in Ischemic Heart Disease Burden in Iran, 1990-2023: A Systematic Review.
    Clin Cardiol. 2026;49:e70487.
    PubMed         Abstract available
    
    

    
    Crit Care Med

27. CHOI KH, Kang D, Seo J, Cha JH, et al
    Geographic Access to Care and Mortality in Cardiogenic Shock: A Nationwide Cohort Analysis.
    Crit Care Med. 2026 Aug 7. doi: 10.1097/CCM.0000000000007287.
    PubMed         Abstract available
    
    

    
    Eur Heart J

28. PARK DW, Boden WE, De Caterina R, Gallinoro E, et al
    Great debate: preventive percutaneous coronary intervention added to optimal medical treatment should be the default treatment for non-flow-limiting vulnerable plaques.
    Eur Heart J. 2026 Mar 6:ehag103. doi: 10.1093.
    PubMed         Abstract available
    
    
29. MAHENDIRAN T, Corradetti S, Perera D, Pijls NHJ, et al
    Coronary autoregulation: the complex interplay between epicardial and microvascular resistance.
    Eur Heart J. 2026;47:5279-5292.
    PubMed         Abstract available
    
    
30. JOHNSON TW, Gonzalo N, de la Torre Hernandez JM, Amabile N, et al
    Intracoronary imaging for left main percutaneous coronary intervention: a clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC and the European Bifurcation Club (EBC).
    Eur Heart J. 2026 May 15:ehag353. doi: 10.1093.
    PubMed         Abstract available
    
    
31. GALLI M, Ten Berg J, Berry C
    Meta-analyses limitations and the compelling case for a contemporary, pragmatic trial of clopidogrel vs aspirin for secondary prevention of coronary heart disease: clopidogrel is not superior to aspirin in non-East Asian patients.
    Eur Heart J. 2026 Oct 10:ehag805. doi: 10.1093.
    PubMed        
    
    

    
    J Am Coll Cardiol

32. MEHRAN R, Carrion-Isaacs E, Procopi N
    From Mapping Disparities to Precision in Cardiovascular Health Equity.
    J Am Coll Cardiol. 2026 Oct 7:S0735-1097(26)07839.
    PubMed        
    
    
33. ZHANG Q, Swoboda P, Lu M, Piechnik S, et al
    REPLY: Virtual Native Enhancement of CMR for Myocardial Infarction Assessment.
    J Am Coll Cardiol. 2026 Sep 26:S0735-1097(26)07710.
    PubMed        
    
    

    
    J Cardiovasc Pharmacol

34. THIRUNAVUKARASU S, Tiong DTW, He M, Das A, et al
    One Month Versus Three Months of Aspirin After Percutaneous Coronary Intervention: A Reconstructed Time-to-Event Analysis.
    J Cardiovasc Pharmacol. 2026 Oct 5. doi: 10.1097/FJC.0000000000001882.
    PubMed         Abstract available
    
    
35. GARSHICK M, Weber B, Marchetta M
    Upadacitinib and Cardiovascular Safety Across Immune-Mediated Inflammatory Diseases: Reassurance Without Certainty.
    J Cardiovasc Pharmacol. 2026 Oct 5. doi: 10.1097/FJC.0000000000001883.
    PubMed        
    
    
36. CAMILLI M, Ortenzi M, Leo L, Viscovo M, et al
    Rationale and Design of the CARdio-Tox Study: A Prospective Evaluation of Cardiovascular Toxicity in Patients Receiving Chimeric Antigen Receptor-T (CAR-T) Cell Therapy.
    J Cardiovasc Pharmacol. 2026 Oct 7. doi: 10.1097/FJC.0000000000001886.
    PubMed         Abstract available
    
    
37. ACIERNO C, D'Ardes D, Boccatonda A, Nilo D, et al
    Targeting Lipoprotein(a) in Cardiovascular Disease: Emerging Therapies and Clinical Implications.
    J Cardiovasc Pharmacol. 2026 Oct 9. doi: 10.1097/FJC.0000000000001887.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

38. SHUFELT CL, Stuart JJ, Karam J, Che X, et al
    Functional Hypothalamic Amenorrhea Phenotype and Cardiovascular Disease Risk.
    J Clin Endocrinol Metab. 2026 Oct 5:dgag405. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

39. RAMDEEN SL, Wagner C, Pegues JN, Yang J, et al
    Patient-Surgeon Sex Concordance Affects Coronary Artery Bypass Grafting Outcomes.
    J Thorac Cardiovasc Surg. 2026 Oct 6:S0022-5223(26)01370.
    PubMed         Abstract available
    
    

    
    JAMA

40. BADVE SV, De Vriese AS, Gallagher M
    Low-Dose Rivaroxaban, Cardiovascular Events, and Kidney Disease-Reply.
    JAMA. 2026 Oct 5. doi: 10.1001/jama.2026.16113.
    PubMed        
    
    
41. COPPI P
    Low-Dose Rivaroxaban, Cardiovascular Events, and Kidney Disease.
    JAMA. 2026 Oct 5. doi: 10.1001/jama.2026.16110.
    PubMed        
    
    
42. ANDERER S
    Whole Grain Intake Tied to Lower Cardiovascular Disease Risk Factors.
    JAMA. 2026 Oct 9. doi: 10.1001/jama.2026.20014.
    PubMed        
    
    

    
    Mol Cell Biochem

43. HOU X, Chen Y, Xu Q, Zhong J, et al
    PHLDA3 hypomethylation at the mercy of PTBP1-mediated DNMT3a decay prompts ferroptosis of cardiomyocytes to accelerate microvascular endothelial cell senescence following ischemia/reperfusion injury.
    Mol Cell Biochem. 2026;481:4215-4239.
    PubMed         Abstract available
    
    
44. WANG H, Liu H, Meng X, Song J, et al
    Trimethylamine N-oxide activates cardiac fibroblasts transformation through NLRP3 inflammasome activation with changes in mitochondrial dynamics and ER-mitochondrial contact under ER stress.
    Mol Cell Biochem. 2026;481:4157-4180.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

45. RAVAUD C, Cuoco CA, Sigal S, Unsworth HM, et al
    Phenotypic screening identifies kenpaullone as a prolymphangiogenic compound to improve heart repair following myocardial infarction.
    Proc Natl Acad Sci U S A. 2026;123:e2619427123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum